Detalles de la búsqueda
1.
A phase II study of cediranib (AZD 2171) in treatment naive patients with progressive unresectable recurrent or metastatic renal cell carcinoma. A trial of the PMH phase 2 consortium.
Invest New Drugs
; 31(4): 1008-15, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23354849
2.
Evaluation of creatinine-based formulas in dosing adjustment of cancer drugs other than carboplatin.
J Oncol Pharm Pract
; 16(2): 113-9, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19578094
3.
Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219.
Lung Cancer
; 133: 48-55, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31200828
4.
Correlations of EGFR mutations and increases in EGFR and HER2 copy number to gefitinib response in a retrospective analysis of lung cancer patients.
BMC Cancer
; 7: 128, 2007 Jul 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-17626639
5.
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer.
Int J Radiat Oncol Biol Phys
; 98(2): 275-285, 2017 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28262473
6.
ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer.
Int J Radiat Oncol Biol Phys
; 98(2): 286-295, 2017 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28433432
7.
A phase I study of foretinib plus erlotinib in patients with previously treated advanced non-small cell lung cancer: Canadian cancer trials group IND.196.
Oncotarget
; 8(41): 69651-69662, 2017 Sep 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29050231
8.
Influence of sex on toxicity and treatment outcome in small-cell lung cancer.
J Clin Oncol
; 23(4): 850-6, 2005 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15681530
9.
Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer.
J Clin Oncol
; 23(27): 6674-81, 2005 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16170175
10.
A phase II, pharmacokinetic, and biological correlative study of oblimersen sodium and docetaxel in patients with hormone-refractory prostate cancer.
Clin Cancer Res
; 11(10): 3854-61, 2005 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15897586
11.
A Phase II Study of PF-03446962 in Patients with Advanced Malignant Pleural Mesothelioma. CCTG Trial IND.207.
J Thorac Oncol
; 11(11): 2018-2021, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27449804
12.
Pan Canadian Rash Trial: A Randomized Phase III Trial Evaluating the Impact of a Prophylactic Skin Treatment Regimen on Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced Skin Toxicities in Patients With Metastatic Lung Cancer.
J Clin Oncol
; 34(8): 810-5, 2016 Mar 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26573073
13.
Asian ethnicity and adenocarcinoma histology continues to predict response to gefitinib in patients treated for advanced non-small cell carcinoma of the lung in North America.
Lung Cancer
; 49(2): 225-31, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15925429
14.
The Influence of the Evolution of First-Line Chemotherapy on Steadily Improving Survival in Advanced Non-Small-Cell Lung Cancer Clinical Trials.
J Thorac Oncol
; 10(11): 1523-31, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26536194
15.
A phase II study of GW786034 (pazopanib) with or without bicalutamide in patients with castration-resistant prostate cancer.
Clin Genitourin Cancer
; 13(2): 124-9, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24993934
16.
Outcomes with abiraterone acetate in metastatic castration-resistant prostate cancer patients who have poor performance status.
Eur Urol
; 67(3): 441-7, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24508071
17.
Thoracic radiotherapy for limited-stage small cell lung cancer: issues of timing, volumes, dose, and fractionation.
Semin Oncol
; 30(1): 26-37, 2003 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-12635087
18.
Targeted molecules in small cell lung cancer.
Semin Oncol
; 31(1 Suppl 1): 106-11, 2004 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-14981588
19.
Population-based outcomes for small cell lung cancer: impact of standard management policies in British Columbia.
Lung Cancer
; 43(1): 7-16, 2004 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-14698532
20.
Carboplatin and vinblastine for the treatment of metastatic transitional cell carcinoma of the urothelial tract.
Am J Clin Oncol
; 25(5): 515-9, 2002 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-12393996